AXSOME THERAPEUTICS, INC. (AXSM) /

The profitability of AXSOME THERAPEUTICS, INC. over the past 10 years

Chart AXSOME THERAPEUTICS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

AXSOME THERAPEUTICS, INC. reported a net loss of $183.17M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $166.76M. It reported a loss in all 10 years shown.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025—-$166.76M-$183.17M
2024ended Dec 31, 2024—-$280.56M-$287.22M
2023ended Dec 31, 2023—-$231.82M-$239.24M
2022ended Dec 31, 2022$44.84M*-$179.8M-$187.13M
2021ended Dec 31, 2021—-$124.71M-$130.4M
2020ended Dec 31, 2020—-$99.14M-$102.9M
2019ended Dec 31, 2019—-$67.25M-$68.35M
2018ended Dec 31, 2018—-$32.85M-$30.97M
2017ended Dec 31, 2017—-$27.16M-$28.94M
2016ended Dec 31, 2016—-$27.54M-$27.2M

Fiscal years as AXSOME THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on AXSOME THERAPEUTICS, INC.

Companies of a similar size

Not investment advice. This page shows what AXSOME THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.